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and G1P[6] along with G2P[4] and 
G9P[8]. Our study results are similar 
to those of recent studies conducted 
in other African countries (5–8) and 
confirm results of studies that found 
that the same genotypes circulated in 
western Cameroon in 2003, albeit at 
different percentages (4,9).
Our study provides relevant data 
about the genotypes of rotavirus-A 
from children in the Central African 
Republic, 25 years after the most re-
cent study (2). These data represent 
baseline information that will help 
with monitoring for potential changes 
in genotype prevalence after the intro-
duction of rotavirus-A vaccine in the 
Central African Republic.
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Genome Analysis  
of Mayaro Virus  
Imported to  
Germany from 
French Guiana
To the Editor: Mayaro virus 
(MAYV), a mosquito-borne New 
World alphavirus of the family To-
gaviridae, causes a febrile arthralgia 
syndrome resembling dengue and 
chikungunya fever. The virus is main-
tained in a natural cycle involving 
nonhuman primates and Haemagogus 
spp. mosquitoes in tropical rainforest 
areas of South America (1). After an 
incubation time of 7–12 days follow-
ing an infectious mosquito bite, rash, 
fever, headache, and arthralgia devel-
op in patients, followed by restoration 
to their original conditions after sev-
eral weeks (1).
Outbreaks of Mayaro fever have 
been reported from the Amazon region 
(1,2). There are increasing reports of 
travel-related infections imported from 
South America to Europe and the Unit-
ed States (3–7). We describe an acute 
MAYV infection in a German traveler 
who returned from French Guiana. 
Full-length MAYV genome amplifica-
tion was performed on virus obtained 
from a serum sample of the patient.
In August 2013, a 44-year-old 
woman (bookkeeper) came to an out-
patient clinic with fever (temperature 
≤38.7°C), chills, a mild headache, 
severe fatigue, highly painful swell-
ing of small finger joints, and pain in 
both feet. Symptoms appeared 2 days 
before when she experienced aches in 
her wrists and left forefoot. Four days 
before, the patient had returned from 
a 2.5-week visit to French Guiana, 
where she traveled with her partner and 
caught butterflies.  She had conducted 
these activities during her holidays for 
the past 5 years, mostly in spring or 
autumn. In July 2013 at the end of the 
rainy season, she had many mosquito 
bites, especially on her hands, despite 
use of repellents and bed nets.
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Physical examination showed a 
body temperature of 38°C, throat en-
anthema, generalized macular exan-
thema, and slightly swollen and tender 
interphalangeal joints of the hands 
and feet. Her medical history was un-
remarkable, and her partner was as-
ymptomatic. Laboratory tests showed 
reference values for hemoglobin con-
centration; platelet count; and levels 
of liver enzymes, creatinine, and anti-
nuclear and anti–citrulline peptide an-
tibodies. C-reactive protein level was 
increased (24.2 mg/L; reference value 
<5 mg/L), and serum lactate dehydro-
genase level was slightly increased 
(4.4 µkat/L; reference value <4.12 
µkat/L). Leukopenia (2.4 G/L; refer-
ence value 4.0–10.0 G/L) was present, 
which intensified the next day (2.0 
g/L). The leukocyte count returned to 
a reference value 8 days after disease 
onset and the patient fully recovered.
Malaria, dengue fever, and rickett-
siosis were excluded by using several 
tests. Blood cultures obtained on day 
2 after disease onset remained sterile, 
and a viral infection was suspected. 
Follow-up investigation on day 16 of 
illness showed an increased IgG titer 
(80) against chikungunya virus (by 
indirect immunofluorescence assay; 
reference value <1:20) (6) but no IgM 
titer. Additional tests for alphaviruses 
were then performed on the same sam-
ple, and indirect immunofluorescence 
assay showed an IgM titer of 2,560 
and an IgG titer of 10,240 (reference 
value <20) (6) against MAYV. Results 
of serologic tests were negative for 
Venezuelan equine encephalitis virus, 
Eastern equine encephalitis virus, and 
Oropouche virus. IgM (80) and IgG 
(160) titers for antibodies against Ross 
River virus were low.
An acute MAYV infection was 
strongly suspected and a stored se-
rum sample from day 2 underwent 
generic reverse transcription PCR 




GTCGTCGCCGATGAA-3′) (8) and 
quantitative MAYV real-time RT-PCR 
(in-house) with primers MayaroF 
(5′-CCTTCACACAGATCAGAC-3′), 
MayaroR (5′-GCCTGGAAGTA-
CAAAGAA-3′), probe labeled with 6- 
carboxyfluorescein (FAM) and black 
hole quencher 1 (BHQ-1) MayaroP 
( 5 ′ - FA M - C ATA G A C AT C C T-
GATAGACTGCCACC-BHQ1 3′) by 
using the AgPath-ID One-Step RT-PCR 
Kit (Life Technologies, Carlsbad, CA, 
USA) according to the manufacturer’s 
instructions. The generic RT-PCR for 
alphaviruses showed a positive result, 
and direct sequencing of the amplicon 
showed a MAYV-specific sequence. 
The serum sample had an MAYV viral 
load of 1.24 × 107 copies/mL when in 
vitro–transcribed RNA from a refer-
ence plasmid was used as a quantifica-
tion standard.
Attempts to isolate MAYV in cell 
culture were not successful. There-
fore, the serum sample was used 
to obtain the complete MAYV ge-
nome sequence by using primers de-
signed from multiple alignments of 
the MAYV genomes obtained from 
databases. (Primer sequences used 
are available on request.) The com-
plete MAYV genome (strain BNI-
1, KJ013266) was amplified from 
the serum sample, and phylogenetic 
analysis of a 2-kb genomic fragment 
showed that strain BNI-1 belonged 
to genotype D (9) and is closely re-
lated to strains circulating in Brazil 
(Figure, http://wwwnc.cdc.gov/EID/
article/20/7/14-0043-F1.htm).
In 2 clinic-based syndromic sur-
veillance studies in South America, 
0.8%–3% of febrile episodes were 
caused by MAYV infection (2,10). In 
travelers, MAYV infections were ac-
quired in tropical rainforest or wildlife 
conservation areas (7) and were some-
times associated with insect-hunting 
activities (5). Successful complete ge-
nome amplification of MAYV strain 
BNI-1 from a clinical sample might 
help identify regions in the MAYV 
genome that undergo rapid mutations 
caused by the isolation process in cell 
culture and improve phylogenetic and 
functional genome analysis. More-
over, the viral load in our patient was 
high enough for efficient transmission 
of MAYV to a susceptible mosquito 
vector (S. Becker, pers. comm.). Thus, 
in disease-endemic regions, patients 
with an acute MAYV infection should 
be protected from mosquito bites dur-
ing the first week of disease to prevent 
spread of the virus.
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Diphtheria-like  
Disease Caused  
by Toxigenic  
Corynebacterium 
ulcerans Strain
To the Editor: Toxigenic Coryne-
bacterium ulcerans is an increasingly 
reported cause of diphtheria in the 
United Kingdom and is often associ-
ated with a zoonotic origin (1,2). Here, 
we report a case of diphtheria caused by 
toxigenic C. ulcerans in a woman, 51 
years of age, from Scotland, UK, who 
was admitted to a hospital in August 
2013 with a swollen, sore throat and a 
gray-white membrane over the pharyn-
geal surface. The patient had returned 
from a 2-week family holiday in the 
state of Florida, United States, before 
the admission and also reported recent 
treatment of a pet dog for pharyngitis. 
The patient was believed to have been 
vaccinated against diphtheria during 
childhood. She was immediately ad-
mitted to an isolation ward and treated 
with a combination of clindamycin, 
penicillin, and metronidazole. 
Microscopic examination of the 
throat biofilm (collected by using a 
swab) showed gram-positive bacilli; 
swab samples from the exudative mem-
brane and throat produced small, black 
colonies indicative of Corynebacterium 
spp. on Hoyle medium. Further efforts 
to  identify the strain by using VITEK 
MS and VITEK2 ANC card systems 
(bioMérieux, Marcy l’Etoile, France) 
to evaluate the swab samples suggested 
that the infection was caused by either 
C. ulcerans or C. pseudotuberculosis 
(50% CI). The isolate detected from this 
process was sent to the Streptococcus 
and Diphtheria Reference Unit, Public 
Health England, Colindale, UK, and 
was confirmed to be a toxigenic C. ul-
cerans strain that we designated RAH1. 
Throat swab samples were collected 
from family members of the patient 
and were negative for C. ulcerans. The 
family dog was not tested for presence 
of the organism, although it is known 
that C. ulcerans infections are often of 
a zoonotic nature (1,2). After treatment, 
the patient made a full recovery.
Toxigenic C. ulcerans can pro-
duce both diphtheria-like and Shiga-
like toxins (3); to identify the genetic 
basis of toxin production and other po-
tential virulence factors in this strain, 
a whole genome sequencing approach 
was applied to the isolate. The genome 
was sequenced by using an Ion PGM 
System (Thermo Fischer Scientific, 
Loughborough, Leicestershire, UK) 
and resulting reads (2,965,044 reads, 
≈90× coverage. Data are available on 
GenBank SRA: high-throughput DNA 
and RNA sequence read archive (http://
www.ncbi.nlm.nih.gov/Traces/sra/sra.
cgi?view=search_obj, accession no.: 
SRR1145126) and were mapped onto 
the published genome sequences of 
a Shiga-like toxin–producing clini-
cal isolate 809, asymptomatic canine 
strain BR-AD22 (3), and diphtheria-
like toxin–producing strain 0102 (4). 
Most of the previously identified viru-
lence genes (3,4) were present in the 
patient isolate (Table). The tox gene, 
encoding diphtheria toxin, was pres-
ent, which verified the diphtheria-like 
disease in the patient. The rbp gene, 
responsible for Shiga toxin–like ri-
bosome-binding protein, was absent. 
However, strain RAH1 also possessed 
the venom serine protease gene (vsp2), 
which, in C. ulcerans strain 809, has 
been implicated in the increased viru-
lence in humans. The tox gene was 
present in a prophage that showed 
similarities to ΦCULC809I (3) and 
ΦCULC0102-I (4). Genome-based 
phylogenetic analysis of the RAH1 
strain (ClonalFrame analysis [5]) and 
strains 809, BR-AD22, and 0102 indi-
cates a much wider phylogenetic diver-
sity of C. ulcerans strains than previ-
ously appreciated (data not shown).
This case raises the issue of waning 
vaccine protection in older patients and 
suggests that toxin-mediated coryne-
bacterial disease remains a threat to pub-
lic health. The declining costs of next-
generation sequencing and availability 
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